Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG
about
A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patientsThe interplay between obesity and cancer: a fly viewProstate Cancer Genetics: Variation by Race, Ethnicity, and Geography.Prognostic outlier genes for enhanced prostate cancer treatment.Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study.Lectin-like oxidized LDL receptor-1 is an enhancer of tumor angiogenesis in human prostate cancer cellsProceedings of the second international molecular pathological epidemiology (MPE) meetingObesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancerA Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.Calcium-Sensing Receptor Tumor Expression and Lethal Prostate Cancer Progression.Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting.Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer.Body mass index and mortality in prostate cancer patients: a dose-response meta-analysis.Lipid catabolism via CPT1 as a therapeutic target for prostate cancer.Obesity and Prostate Cancer: A Focused Update on Active Surveillance, Race, and Molecular Subtyping.Perineural Invasion and Risk of Lethal Prostate Cancer.PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer.Midlife Cardiorespiratory Fitness, Incident Cancer, and Survival After Cancer in Men: The Cooper Center Longitudinal Study.Deletion of Interstitial Genes between TMPRSS2 and ERG Promotes Prostate Cancer Progression.Cancer-specific mortality of Asian Americans diagnosed with cancer: a nationwide population-based assessment.Height, obesity, and the risk of TMPRSS2:ERG-defined prostate cancer.A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer.Hyperglycemia Promotes TMPRSS2-ERG Gene Fusion in Prostate Cancer Cells via Upregulating Insulin-Like Growth Factor-Binding Protein-2.STAMP2 is required for human adipose-derived stem cell differentiation and adipocyte-facilitated prostate cancer growth in vivo.Prostate cancer: Race and prostate cancer personalized medicine: the future.Prostate cancer incidence, clinical stage and survival in relation to obesity: a prospective cohort study in Denmark.Obesity and Prostate Cancer.The Differential Impact of Body Mass Index and the Feature of Metabolic Syndrome on Oncological Outcomes Following Different Surgical Procedures in Japanese Men with Prostate Cancer.Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.
P2860
Q28076622-3197B289-0C23-4405-A083-2F745033D89EQ28079088-D8711455-0734-4635-8910-B838524F0500Q30240027-6F190213-5A67-409D-BDF1-E66177BCF9EAQ30244674-C514F493-86C6-430E-BF70-B3761DD5CEACQ33901167-D24984C3-D346-4575-992B-386413B89D94Q34110474-3BE322BC-3CBC-41AA-92A2-854136292D49Q34475686-A43725D9-6556-435B-8C6F-5E12ECAF0336Q35535396-8DAE0DE6-C938-4F95-A537-50D413FA317DQ36738856-24632201-91B1-41E7-AF7D-2F741EDA9928Q36887707-205F8887-00ED-4824-A65C-3AD2F8CB0DC4Q36965321-F5BE95FE-25F1-4E60-AC16-97EA4568515BQ38264014-5C008250-5546-4FA0-A4AB-25AA6AD61769Q38431342-B01F8364-0B7D-4458-B23D-77E699566E32Q38692737-7EA12F7E-E63B-42BA-98B7-8ECEC35E2B49Q38966211-E8E47AB0-5AC6-4B2C-8317-EEAD4264890EQ38988252-B8BDC8CF-10FC-44AB-9A3D-64AC7FE1B186Q39035046-5E269EDC-53E7-4887-AAAE-D58237AEB676Q39401816-1F73D9B5-4A4A-468B-BC34-E124EB03CF71Q40730062-CD487A17-5D27-4C8D-99DD-07BDBA3FFA45Q40908009-2DBF94AB-ECF6-4A05-8474-AC6A7AB26022Q41186635-BD490B5F-0318-451C-8BA1-414CDF931CC5Q45944320-37F125B3-2C74-4CE7-9A28-83731BA9B055Q46694127-F2907FC1-098C-4F28-B4FB-A974E55BA57BQ47147823-F2146B7E-A309-4E9B-8322-529529DBE114Q47155178-F186F13E-B06A-42B4-966F-D7A7871643BCQ47731144-110C4AF1-E9A2-4B4C-87D7-830F7570DBE4Q50562635-78609871-E9B6-4A27-8F89-4DDD09C9259EQ50856725-D4E51C87-86BE-4D25-B456-6C4F353BAA21Q52952837-1D545F9D-7132-4F13-AD72-21859D2173A3Q54474207-06863398-D60C-4DCB-A992-E0BEF6DBC7E0
P2860
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG
@en
Modification of the associatio ...... rostate cancer by TMPRSS2:ERG.
@nl
type
label
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG
@en
Modification of the associatio ...... rostate cancer by TMPRSS2:ERG.
@nl
prefLabel
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG
@en
Modification of the associatio ...... rostate cancer by TMPRSS2:ERG.
@nl
P2093
P2860
P50
P356
P1476
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG
@en
P2093
Allison Meisner
Andreas Pettersson
Edward C Stack
Elizabeth J Nuttall
Howard D Sesso
Kathryn L Penney
Michael Pollak
Michelangelo Fiorentino
Neil E Martin
Rebecca E Graff
P2860
P304
P356
10.1093/JNCI/DJT332
P407
P50
P577
2013-11-30T00:00:00Z